Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

269
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
269
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Impairment in stimulus-response learning as a cognitive biomarker in a model of synucleinopathy.

Translational psychiatry·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Synthesis and Characterization of Click Chemical Probes for Single-Cell Resolution Detection of Epichaperomes in Neurodegenerative Disorders.

Biomedicines·2024
Same author

Maternal exposure to bisphenol S reduces anxiety and impairs collective antipredator behavior of male zebrafish (Danio rerio) offspring through dysregulation of their serotonergic system.

Aquatic toxicology (Amsterdam, Netherlands)·2024
Same author

Neuroanatomical and cognitive biomarkers of alpha-synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms.

Journal of neurochemistry·2023
Same author

Effects of common antiepileptic drugs on teleost fishes.

The Science of the total environment·2023
Same journal

Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Human brain connectome profiles mediate the relationship between pathology burden and clinical phenotypes in Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Kat5 cKO mouse replicates biological domain signatures associated with Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Associations of self-reported obstructive sleep apnea with cognition and dementia risk in cognitively unimpaired middle-aged adults.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Ver todos los artículos relacionados
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

Anoosha Attaran1

  • 1The University of Western Ontario, London, ON, Canada.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
Resumen
Este resumen es generado por máquina.

El desarrollo de una nueva línea preclínica utilizando ratones humanizados y biomarcadores avanzados mejora la precisión del descubrimiento de fármacos para sinucleinopatías como la enfermedad de Parkinson (EP). Este enfoque mejora la predicción de los resultados del tratamiento para enfermedades neurodegenerativas.

Palabras clave:
ratones humanizadosbiomarcadores avanzadossinucleinopatíasdescubrimiento de fármacosenfermedad de Parkinsonenfermedades neurodegenerativas

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

446

Área de la Ciencia:

  • Neurociencia; Farmacología

Sus antecedentes:

  • La población mundial de adultos mayores está creciendo, lo que lleva a una mayor prevalencia de enfermedades neurodegenerativas, incluidas las sinucleinopatías (enfermedad de Parkinson, demencia con cuerpos de Lewy, enfermedad de Alzheimer).; El desarrollo de fármacos para sinucleinopatías enfrenta desafíos debido a la pobre traslación de los modelos animales y a biomarcadores cognitivos limitados para predecir el éxito del tratamiento.; La investigación actual tiene como objetivo crear una línea preclínica integral de descubrimiento de fármacos que integre ratones humanizados, biomarcadores neuroquímicos, de imagen y cognitivos para mejorar la precisión predictiva.

Objetivo del estudio:

  • Desarrollar y validar una línea preclínica de descubrimiento de fármacos para sinucleinopatías.; Mejorar la precisión predictiva de la eficacia terapéutica y los efectos adversos utilizando biomarcadores integrados.; Mejorar la traslación de los hallazgos preclínicos al éxito clínico para los tratamientos de enfermedades neurodegenerativas.

Principales métodos:

  • Se utilizaron inyecciones de fibrillas preformadas (PFF) de sinucleína humana en modelos de ratones humanizados.; Se emplearon tareas cognitivas de alto rendimiento basadas en pantallas táctiles para evaluar los déficits cognitivos.; Se integró la fotometría de fibra para la dinámica de la dopamina, la inmunofluorescencia, la microscopía de hoja de luz y la RMN para evaluaciones patológicas y anatómicas.; Se iniciaron experimentos para probar intervenciones terapéuticas, incluidos fármacos, manipulaciones genéticas y vacunas contra la toxicidad de la alfa-sinucleína (a-Syn).

Principales resultados:

  • Los ratones inyectados con PFF mostraron déficits cognitivos significativos en tareas de discriminación visual y aprendizaje condicional antes de los déficits motores.; Se observaron dinámicas dopaminérgicas alteradas en ratones inyectados con PFF que se comportaban libremente.; Los cambios cognitivos y neuroquímicos se correlacionaron con un aumento de la extensión de la alfa-sinucleína fosforilada a través de las redes córtico-estriado-talámicas.; La RMN reveló patrones de atrofia espacial que imitan la sinucleinopatía humana.; Los datos preliminares sugieren que los tratamientos pueden mitigar la toxicidad de la alfa-sinucleína y mejorar los déficits cognitivos.

Conclusiones:

  • Se estableció una línea preclínica que integra ratones humanizados, tareas cognitivas, monitorización neuroquímica e imagenología.; La línea demuestra potencial para una mejor predicción de la eficacia terapéutica y los efectos adversos en sinucleinopatías.; El objetivo es acelerar el desarrollo de tratamientos eficaces para las sinucleinopatías y reducir los fracasos de los fármacos en etapas tardías.